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Detailed Analysis of Sequence Changes Occurring during
vlsE Antigenic Variation in the Mouse Model of Borrelia
burgdorferi Infection
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1Department of Pathology and Laboratory Medicine, University of Texas Medical School at Houston, Houston, Texas, United States of America, 2Department of
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Abstract
Lyme disease Borrelia can infect humans and animals for months to years, despite the presence of an active host immune
response. The vls antigenic variation system, which expresses the surface-exposed lipoprotein VlsE, plays a major role in B.
burgdorferi immune evasion. Gene conversion between vls silent cassettes and the vlsE expression site occurs at high
frequency during mammalian infection, resulting in sequence variation in the VlsE product. In this study, we examined vlsE
sequence variation in B. burgdorferi B31 during mouse infection by analyzing 1,399 clones isolated from bladder, heart, joint,
ear, and skin tissues of mice infected for 4 to 365 days. The median number of codon changes increased progressively in
C3H/HeN mice from 4 to 28 days post infection, and no clones retained the parental vlsE sequence at 28 days. In contrast,
the decrease in the number of clones with the parental vlsE sequence and the increase in the number of sequence changes
occurred more gradually in severe combined immunodeficiency (SCID) mice. Clones containing a stop codon were isolated,
indicating that continuous expression of full-length VlsE is not required for survival in vivo; also, these clones continued to
undergo vlsE recombination. Analysis of clones with apparent single recombination events indicated that recombinations
into vlsE are nonselective with regard to the silent cassette utilized, as well as the length and location of the recombination
event. Sequence changes as small as one base pair were common. Fifteen percent of recovered vlsE variants contained
‘‘template-independent’’ sequence changes, which clustered in the variable regions of vlsE. We hypothesize that the
increased frequency and complexity of vlsE sequence changes observed in clones recovered from immunocompetent mice
(as compared with SCID mice) is due to rapid clearance of relatively invariant clones by variable region-specific anti-VlsE
antibody responses.
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Introduction
Lyme borreliosis is caused by Borrelia burgdorferi and other
members of the genus Borrelia, and is the most prevalent vector-
borne disease in the United States [1]. Spirochetes are transmitted
to mammalian hosts by Ixodes ticks, causing a local skin infection,
usually accompanied by a lesion called erythema migrans. As the
infection advances, Borrelia disseminate into deeper tissues despite
a strong immune response against the pathogen [2–6]. However,
Lyme disease Borrelia are able to escape clearance and cause
disease manifestations (including neurologic, arthritic, cardiovas-
cular, and dermatologic symptoms) for months to years after the
initial infection.
Antigenic variation results from changes in surface antigen
genes that occur during the course of infection at rates higher than
the expected mutation frequency [7]. This mechanism is
particularly important for organisms that cause long-term or
repeated infections. Pathogens with antigenic variation systems are
able to evade the immune response, thus gaining a selective
advantage over their more antigenically stable counterparts and
posing a challenge in the development of vaccines. Influenza virus
[8] , HIV [9], Neisseria gonorrhoeae and N. meningitidis [10],
Mycoplasma synoviae [11], Mycoplasma pulmonis [12], Anaplasma
marginale [13], Borrelia burgdorferi [14], Borrelia hermsii [15,16],
Treponema pallidum [17], Campylobacter jejuni [18], Candida species
[19], Plasmodium falciparum [20] and Trypanosoma brucei [21] are
some examples of viruses, bacteria, fungi and parasites that avoid
immune clearance through antigenic variation.
A surface-exposed lipoprotein, VlsE, contributes to immune
evasion and persistence of Lyme borreliosis organisms in infected
mammalian hosts through an elaborate antigenic variation
mechanism [14,22–25] . The Vmp-like sequence (vls) locus of B.
burgdorferi B31 is located on the linear plasmid lp28-1. The vls locus
is composed of an expression site (vlsE) encoding the 35 kDa
lipoprotein VlsE and a contiguous array of 15 unexpressed (silent)
vls cassettes. The silent cassettes have high homology to the central
cassette region of vlsE (90.0% to 96.1% nucleotide sequence
identity and 76.9% to 91.4% predicted amino acid sequence
identity), and most of the sequence differences are concentrated in
six variable regions within each cassette [22]. Clones lacking lp28-
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1 exhibit an intermediate infectivity phenotype, characterized by
decreased persistence and aberrant tissue distribution in immu-
nocompetent mice but no change in virulence in SCID mice
[24,26,27]. Recent studies by Bankhead and Chaconas [23]
demonstrated that removal of the vls locus by telomere-mediated
truncation resulted in the same phenotype as the loss of lp28-1,
whereas truncation of the other end of the plasmid had no
detectable effect on mouse infection by needle inoculation. These
results support the role of the vls locus in immune evasion.
Previous analysis of a limited number of clones recovered from
experimentally infected mice or rabbits indicated that vlsE
sequence variation occurs within 4 days and continues throughout
the course of infection [25,28]. Only the cassette region of the vlsE
is subject to sequence variation during these recombination events.
Segments of the vls silent cassette sequences replace portions of the
vlsE cassette region through a gene conversion process, such that
the sequence and organization of the silent vls cassettes remain
unaltered [14]. vlsE antigenic variation has not been detected
during in vitro culture or during tick infection, but occurs during
mammalian infection in both immunocompetent and severe
combined immunodeficiency disease (SCID) animals
[14,22,25,29,30]. Attempts to induce vlsE recombination ex vivo
have been unsuccessful. Therefore, the induction of vlsE
recombination occurs through an as yet unidentified signaling
mechanism.
Most sequence changes that occur during vlsE recombination
events are localized within the six variable regions. The six invariable
regions within the cassette region [22] contain relatively few variable
codons and are likely to be important in preserving overall protein
structure and biological function [31]. The variable regions form
random coil structures on the membrane distal surface of the protein
where antibody interactions are most likely [31]. Immunoglobulins
specific for these regions are generated during the course of infection
[32]. Also, the resulting variants exhibit decreased reactivity to
antisera raised against a recombinant form of the vlsE cassette region
from the parental clone; indicating that the sequence changes result in
real antigenic variation [22]. The mechanisms that promote the
selectivity and unidirectionality of gene conversion in the vls locus
have not been identified.
In the current study, B. burgdorferi clones acquired 4 to 365 days
following infection of immunocompetent or SCID mice were
examined to gain a better understanding of the vlsE recombination
process. The results provide further evidence of the remarkable
randomness of recombination events occurring within the vlsE
cassette region.
Results/Discussion
Prolonged persistence of clones possessing the parental
vlsE sequence in SCID mice
We analyzed the vlsE cassette region sequences of 1399 clones
recovered during the time course of infection of immunocompe-
tent C3H/HeN and immunocompromised C3H/HeN SCID and
CB-17 SCID mice (Table 1). These results comprised 85
previously reported clones [14,22] and 1320 clones derived during
this study. The earlier studies were performed with B. burgdorferi
B31clone 5A3 and utilized CB-17 SCID mice, whereas our recent
analyses used clone B31 5A4 and C3H/HeN SCID mice.
Although clone 5A3 is lacking plasmids lp28-2 and lp56 and
CB-17 mice have a different genetic background than C3H/HeN,
the results obtained were comparable (data not shown); therefore,
the results obtained with the two B. burgdorferi B31 clones and the
two SCID mouse strains were combined to increase the number of
isolates and time points analyzed without necessitating additional
animal experiments. Bladder, heart, joint, ear and back skin biopsy
isolates were obtained to examine the rate and nature of vlsE
recombination occurring in different tissues. In the current
analysis, we focused on days 4, 7, 10, 14 and 28 post-inoculation
because individual recombination events can be discerned more
commonly at these earlier time points.
As previously observed [25], we found that clones had already
undergone vlsE recombination within 4 days post infection in both
immunocompetent and SCID mouse models (Figure 1). In
immunocompetent mice, only 50% of the retrieved spirochetes
retained the parental vlsE sequence after 4 days of infection,
meaning that the remaining 50% of the population had already
incurred one or more vlsE recombination events. By 14 days post
infection, clones with the parental vlsE sequence were few in
number (3% of all examined) and were not detected at 28 days
after inoculation (Figure 1). In SCID mice, 87% of the recovered
bacteria retained the parental vlsE sequence at 4 days post
infection. The proportion of parental bacteria decreased more
slowly than in immunocompetent mice, such that parental clones
represented 18.7% and 15% of the populations recovered in SCID
mice at 14 and 28 days post infection, respectively.
The parental bacteria thus persisted longer in the absence of an
adaptive immune response. The rapid clearance of the parental
genotype in immunocompetent mice actually preceded the
detection of anti-VlsE antibodies by ELISA 8 days post infection
in C3H/HeN mice [33]; this result suggests that the anti-variable
region immune responses are present in small quantities within a
few days of infection and are extremely effective in eliminating
clones expressing the corresponding variable region epitopes. The
more gradual decrease in the proportion of parental clones in
SCID mice most likely represents the simple dilution of the initial
genotype by variant clones.
Reduced persistence of clones showing the parental vlsE
sequence in heart and bladder in immunocompetent
mice
At 4 days post infection, only the back skin biopsies (taken at a
site distant from the inoculation site) and blood samples (not
shown) exhibited positive culture results in C3H/HeN and SCID
Author Summary
Lyme borreliosis is the most common vector-transmitted
infection in Europe and North America, and is caused by the
spirochete Borrelia burgdorferi and other closely related
Borrelia species. Lyme disease Borrelia have an elaborate
mechanism for varying the sequence of VlsE, a surface-
localized, immunogenic lipoprotein. This antigenic variation
is thought to be important in immune evasion and thus in
the ability of Lyme disease Borrelia to cause long-term
infection. In this study, we examined 1,399 B. burgdorferi
clones isolated from infected immunocompetent and
immunodeficient mice to gain a better understanding of
the rate and variety of VlsE sequence changes that occur
during infection. We determined that clones with few or no
VlsE sequence changes are rapidly cleared in mice with active
immune responses, whereas clones with many VlsE changes
persist. The vls antigenic variation system can utilize any of
the 15 silent cassette sequences as sequence ‘‘donors,’’ and
does not exhibit obvious preferences in the location of
changes within the vlsE cassette region or the types of VlsE
sequence variations found in different tissues, such as in
joints or in the heart. Our findings provide further evidence
that the vls locus represents a remarkably robust recombi-
nation system and immune evasion mechanism.
vlsE Recombination in Mice
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mice, suggesting that the spirochete had not colonized the other
tissues examined to a detectable extent at this early time point
(Table 1, Figure 2). At 7 days post infection in both mouse models,
samples from the ear pinnae did not yield positive cultures, while
all other sites were culture positive; this result indicates that the
colonization of the external ear takes more time than the other
tissues tested (Table 1, Figure 2). In comparing the different
tissues, the proportion of clones with the parental vlsE sequence
was not significantly different in either mouse model at day 7 post
infection. Thereafter in C3H/HeN mice (but not in SCID mice),
the proportion of parental clones dropped drastically in bladder,
heart, and skin samples between 7 to 10 days post infection and in
joint and ear samples between 10 and 14 days post infection
(Figure 2A). These results indicate that the parental bacteria are
cleared more quickly (or, alternatively, undergo more rapid vlsE
recombination) in bladder, heart and skin than in joint and ear
tissues in immunocompetent mice.
The more rapid clearance of B. burgdorferi with the parental vlsE
sequence in heart, bladder and skin may indicate a higher
accessibility of the bacteria to the adaptive immune system in these
sites. Alternatively, bacteria in joint and ear tissues may localize in
immunoprotective niches (e.g. in relatively avascular or highly
collagenous regions) that allow those expressing the parental vlsE
sequence to survive longer. In previous studies, it has been
demonstrated that, in immunocompetent mice, B. burgdorferi clones
lacking lp28-1 [24,26,33] or the vls locus [23] persist for longer
periods in joint tissue than in other tissues. In contrast, organisms
with these genotypes are able to infect and disseminate to all tested
tissues in SCID mice. These results support the concept that
immune evasion mechanisms provided by VlsE expression and
sequence variation promote the survival of B. burgdorferi, but that
bacteria that either do not express VlsE or have not undergone
sequence variation are relatively protected in some tissues, such as
those present in the tibiotarsal joint.
Accelerated accumulation of vlsE sequence changes in
the presence of the adaptive immune response
We analyzed more specifically the population of variants
(n = 1,073) by excluding all clones with the parental vlsE sequence
(n = 326). The group of variants included 921 ‘unique’ variant
sequences and 158 additional sibling clones (i.e. variants with the
same sequence in the same tissue specimen). The number of codon
changes observed was paralleled closely by the number of amino
acid changes (Figure 3), in concordance with the high proportion
of nonsynonymous codon differences in the silent cassettes that
serve as templates for these sequence changes.
In immunocompetent mice, the median number of codon or
amino acid changes in the vlsE variant clones did not increase
significantly between 4 to 10 days post infection, but at 14, 21 and
28 days post infection the number of changes increase rapidly and
significantly (Figure 3A; P,0.001 for differences in the median
number of changes on days 10 and 14, days 14 and 21, and days
21 and 28). There was no significant difference in the median
number of changes at 28 days and 365 days post infection. The
Table 1. Number of vlsE sequences analyzed from different tissues and time points during experimental infection of
immunocompetent C3H/HeN mice or SCID mice with B. burgdorferi B31.
Days post infection No. of sequences
C3H/HeN SCIDa
Bladder Heart Joint Ear Skin Bladder Heart Joint Ear Skin
4 NCb NC NC NC 43* NC NC NC NC 231*
7 72 71 76 NC 6* 4 15 20 NC ND
10 61 59 60 60 NDc 34 27 28 24 ND
14 49 40 57 55 10* 21 39 31 47 91*
21 ND ND ND ND 48* ND ND ND ND ND
28 42* 49* 40* 19* 17* 441* 411* 201* ND 23 1*
214 ND ND ND ND 7* ND ND ND ND ND
365 3* ND ND ND 5* ND ND ND ND ND
B. burgdorferi B31 Clones 5A4 or 5A3 (asterisks) were injected subcutaneously 105/mouse at the base of the tail. Groups of 4 to 6 mice were sacrificed on the indicated
days post infection.
Cultures from the tissue sites (urinary bladder, heart, tibiotarsal joint, ear pinnae and skin punch biopsies) were acquired under aseptic conditions and clones obtained
by subsurface colony formation in agar plates.
aSCID mice were either C3H/HeN SCID or CB-17 SCID (1).
bNC= no positive cultures obtained.
cND= cultures not done.
doi:10.1371/journal.ppat.1000293.t001
Figure 1. B. burgdorferi clones having the parental vlsE
sequence are cleared more rapidly during infection of
immunocompetent C3H/HeN mice than in immunodeficient
SCID mice. The numbers in parentheses represent the total number of
clones at each time point.
doi:10.1371/journal.ppat.1000293.g001
vlsE Recombination in Mice
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process of recombination in vlsE is still functional after 28 days, but
the number of changes relative to the parental strains becomes
asymptotic [25], as addressed further below. In immunocompro-
mised mice, the number of codon or amino acid changes in vlsE was
not significantly different when comparing 4 days and 14 days post
infection (P.0.05). On days 14 and day 28, the number of changes
was significantly lower in SCID mice than in immunocompetent
C3H/HeN mice (P,0.001, Figure 3A and B). Thus, the immune
pressure provided by the adaptive immune system not only results in
the more rapid elimination of parental clones (Figure 1), but also
selects for clones with more sequence changes and hence antigenic
differences. These findings are again consistent with the observation
that the presence of lp28-1 or, more specifically, an intact, functional
vls locus [23] is required for long-term survival of B. burgdorferi in
immunocompetent mice, but not in SCID mice.
Analysis of recombination events
Each of the 1,073 clones that had undergone vlsE sequence
variation was examined individually to provide a global view of the
length, location, and most likely silent cassette sources of the
recombination events. As in previous analyses of vlsE sequence
variation, segmental gene conversion events were observed; in no
instance was the entire cassette region of vlsE replaced by a silent
cassette. In most cases, the sequence changes could be attributed
to a particular silent cassette sequence or set of potential donor
sequences. However, in many instances, the donor sequence could
not be identified unequivocally due to the high degree of sequence
redundancy among the silent cassettes. Tentative identifications of
recombination events and the corresponding donor sequences
were thus based on those sequence alignments that incorporated
the longest stretch of sequence changes (minimal recombination
event) flanked by regions that were shared between the parental
vlsE and vls silent cassette sequences (constituting the maximal
possible recombination event).
We developed a method for visual, semi-automated analysis of
the recombination events using Visual Basic macros in an Excel
spreadsheet. An example is shown in Figs. 4A and 4B, in which the
sequence of clone D10M8H8 (a variant isolated from a C3H/HeN
mouse heart 10 days post infection) was aligned with the parental
vlsE sequence and each of the silent cassette sequences. Each silent
cassette (vls2 through vls16) is represented sequentially by a
different colored bar. Solid color regions represent individual
codons that have undergone a sequence change and match the
corresponding silent cassette in the aligned sequences. Hatched
color regions are contiguous codons that match both the parental
and silent cassette sequences in that part of the alignment. As
shown in Figure 4B, silent cassette vls13 (arrow) represents the
most likely donor sequence due to the uninterrupted region of
sequence identity spanning VR2 and VR3. Many silent cassettes
match at one or more codons in this region, due to the high degree
Figure 2. Relative persistence of clones retaining the parental vlsE sequence at different tissue sites during the course of infection
of C3H/HeN and SCID mice. Panel (A) represents data obtained from C3H/HeN mice, whereas Panel (B) contains data from SCID mice. Results for
each time point are presented in the order shown (bladder, heart, joint, ear, and skin). - No data available (no positive culture obtained, or culture not
done). 0 No parental sequences identified for that tissue and timepoint.
doi:10.1371/journal.ppat.1000293.g002
vlsE Recombination in Mice
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of redundancy among the vls at the individual codon level.
However, vls13 is the only silent cassette that provides a
contiguous match over this entire region. It is interesting to
note that vls13 is the most likely donor sequence in two regions of
the D10M8H8 sequence, separated by a short sequence that
matches the parental vlsE sequence but not the vls13 sequence
(Figure 4A). Thus this variant may represent an example of
intermittent recombination (see below).
The lengths of predicted minimum recombinations varied
widely, from a single nucleotide change (e.g. variant D7M5J12,
Figure 4C) to a region of at least 372 nucleotides (e.g. variant
D14M2B01, Figure 4C). In some cases, especially at early time
points, some variant sequences exhibited several distinct regions of
gene conversion using apparently the same silent cassette source,
separated by regions of unchanged parental sequence (e.g. variants
D10M8H8 [Figure 4A] and D7M6H09, [Figure 4C]). This
‘skipping’ appears to be due to alignment of a silent cassette
sequence with the vlsE sequence over a long distance, followed by
intermittent strand invasion and replacement of the vlsE sequence
or intermittent cleavage of a single invaded strand. These
observations indicate the occurrence of so-called ‘‘intermittent
recombination events’’ in vlsE. An apparent intermittent recom-
bination event in B. burgdorferi had been reported previously by
Knight et al. [34]; in this case, a sequence containing the putative
Shine Delgarno sequence had been ‘skipped’ during targeted
allelic exchange of the gyrase A C-terminus (gac) gene.
Template-independent sequence changes
Most of the sequence changes in vlsE could be explained as
straight-forward genetic recombinations from silent cassette
sequences to vlsE. However, genetic changes that could not be
attributed to simple gene conversion events with silent cassette
sequences were found in 167 clones (Table S1 and Figure S1).
These ‘template-independent’ changes encompassed a variety of
genetic events ranging from single nucleotide changes, apparent
illegitimate recombination events, triplet repeat expansions/
contractions, or other insertions or deletions of up to 9 base pairs;
they also tended to cluster in the variable regions (Figure S2).
Certain codons had particularly high rates of template-indepen-
dent sequence changes; for example, template-independent
sequence changes of codons 73–75 were identified in 19 variant
sequences isolated from 10 different animals (11% of template-
independent clones). Similarly, sequence variants containing
template-independent changes of codons 194–199 were isolated
23 times from 13 different animals (14% of template-independent
clones). It is unclear whether these areas represent mutation
‘hotspots’ or whether mutations arising in the variable regions are
more likely to be maintained due to their location. The crystal
structure of VlsE [31] reveals that the variable regions (VRs) form
loop structures at the membrane distal surface of VlsE while the
invariant regions (IRs) form structured alpha helical bundles.
Mutations arising in the IRs might destabilize the proteins.
Conversely, mutations in the VRs may aid the organism in
antigenic variation and be maintained preferentially.
We did recover a large number of clones showing deletions or
mutations in one IR region. Codons 10–15 in IR1 contained
deletions or template independent changes in 24 variants from 12
different animals (14% of template-independent clones). Sequence
changes in this region included a group of 7 variants (the last
clones listed in Table S1) in which related sequences differed at
between 9 and 12 of 18 nt in the vlsE1 sequence. These clones
originated from skin and joint tissues of one mouse and the skin
from another mouse 14 days post infection in the same
experiment. These 18 nt sequences were not found elsewhere in
the B. burgdorferi B31 genome sequence, so their source is unknown.
(They are not cloning artifacts, because the PCR products were
sequenced directly without cloning.) The amino acid sequence in
this segment of VlsE1 is LLDKLV, whereas the corresponding
variant sequences are SAVRKE, SAVQQK, SAVRQE and
SADQKE. This region of IR1 is part of the a3 alpha helix in the
VlsE structure [31]. Interestingly, the variant sequences preserve
the alpha helical structure according to protein structure
prediction programs (data not shown); thus these replacements
most likely would not disrupt VlsE secondary structure.
Overall, sequences containing template-independent changes
represented 15% (169 of 1,073) of vlsE variants, reinforcing the
conclusion that they occur at a rate much higher than found in the
rest of the B. burgdorferi genome [35]. These genetic mechanism(s)
therefore may play an important role in antigenic variation of vlsE.
Remarkably, only two of the 169 template-independent changes (a
frame shift in D10M8H7 and a stop codon in SD14M4E1)
represented interruptions in the open reading frame, indicating
that the genetic mechanism(s) and/or selective pressure favor
preservation of the full-length vlsE gene.
Progressive recombination in the vlsE locus
Many vlsE clones appear to have undergone multiple recom-
bination events. No direct lineage of recombinations could be
identified in most cases due to the high degree of sequence
variation. In rare instances, we were able to identify clones that
were likely in the same ‘recombination lineage’, i.e. represented a
sequential series of recombinations. Figure 5 shows an example of
three clones, recovered from a single day 14 mouse bladder
specimen, that have apparently undergone sequential recombina-
Figure 3. Median number of vlsE codon changes and predicted
amino acid changes in variants during the time course of
infection of C3H/HeN or SCID mice. Clones with the parental vlsE
sequence were excluded from this analysis. (A) vlsE codon changes. (B)
Predicted amino acid changes. ** indicates a significant difference
(P,0.01) between organisms from C3H/HeN and SCID mice at the time
points indicated, as calculated by unpaired Student’s t test. - No data
available (culture not done).
doi:10.1371/journal.ppat.1000293.g003
vlsE Recombination in Mice
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Figure 4. Schematic representation of vlsE recombination patterns. (A) Upper panel represents the locations of the 6 invariable regions (IR)
and the 6 variable regions (VR) within the vlsE cassette region. Lower panel illustrates the pattern of recombination of clone D10M8H8 showing
sequence changes between VR1 to VR5. (B) Magnified region of D10M8H8 recombination pattern. The top portion of the diagram shows the
alignment between the parental vlsE sequence (vlsE1), the vls silent cassettes vls2 through vls16, and the vlsE variant. The line ‘‘differences’’ highlights
the difference between the vlsE and the variant sequences. In the lower panel, each colored line schematically represents regions of the 15 silent
cassette sequences which could be involved in the variant sequence changes. Each dark colored block represents a region of sequence change within
the variant sequence that is present in the selected silent cassette sequence. The light colored regions in each line represent segments adjacent to
sequence changes that are identical in vlsE1, the variant and the selected silent cassette sequence (i.e. the maximal possible recombination region).
From this analysis, two likely recombination events using silent cassette vls13 (green) as template were identified: from VR1 to VR3 (arrow, panel B)
and from VR4 to VR5 (see panel A). (C) Recombination patterns obtained for variant sequences, exemplifying the following patterns: a single codon
change involving any one of several possible silent cassettes (D7M5J12), a long recombination event with silent cassette 8 spanning VR2 through VR6
(D14M2B01), and 4 intermittent recombination events involving silent cassette 13 (D7M6H9).
doi:10.1371/journal.ppat.1000293.g004
vlsE Recombination in Mice
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tion events. In panel A, the first clone, D10M10B3 was predicted
to be the result of an intermittent recombination with vls5 (the only
silent cassette that contained all the sequence changes observed in
both regions). The other two clones in the panel, D10M10B1 and
D10M10B21, had the same sequence changes as D10M10B3 but
also contain significant differences in other variable regions. Both
clones contained identical sequence changes in the VR1 region
that suggest a recombination event involving silent cassette 12 took
place in a daughter of D10M10B3. However, D10M10B1 and
D10M10B21 differ in VR6, consistent with these clones having
undergone additional recombination events. Both clones con-
tained sequence changes that are consistent with recombination
with silent cassette 10 in VR6, but clone D10M10B21 exhibited
additional changes in VR6 that suggest another recombination
event with silent cassette 8 at some time following the
recombination with vls10. Panel B summarizes the postulated
sequence of recombination events: an initial recombination with
vls5, followed by recombinations with vls12 and vls10 (in either
order) and a final recombination with vls8 in clone D10M10B21.
Thus we propose that these clones represent a series of sequential
recombinations.
Increased accumulation of putative recombination
events in the presence of the adaptive immune system
The median number of putative recombination events per clone
was tabulated for each time point post infection (Figure 6). This
Figure 5. Progressive recombination in vlsE variant clones. (A) Schematic representation of possible recombination events for three clones
derived from a single day 10 bladder culture. The shaded gray boxes indicate the variable regions (VR). Colored bars represent the maximum possible
length of DNA involved in a putative recombination event for each vls silent cassette. Dark colored blocks within the colored bars represent observed
sequence changes between vlsE and the variant sequence that are present in the selected silent cassette. (B) Postulated sequence of recombination
events leading to the three clones.
doi:10.1371/journal.ppat.1000293.g005
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value was found to increase significantly during the infection of
immunocompetent C3H/HeN mice between day 7 and day 28
post infection (P,0.0001, Figure 6). The higher number of
recombination events identified at 214 days and 365 days post
infection provides further evidence that recombination continues
to occur throughout the course of infection. On day 4 post
infection, the number of recombination events is probably over-
estimated, because several variant sequences contained intermit-
tent recombination events (see below); by default, we considered
an intermittent recombination as multiple recombination events.
In contrast to the results obtained with immunocompetent mice,
the number of deduced recombination events did not increase
significantly between day 4 and day 28 post infection in SCID
mice. These results again support a role of the adaptive immune
system in the selection of clones with a higher number of putative
recombination events. In a previous study, Anguita, et al. [36]
examined a small number of B. burgdorferi clones and reported that
the recombination at the vls locus is impaired in the absence of
interferon (IFN)-c-mediated signals. The proportion of clones that
initiate vlsE gene conversion and the average numbers of changes
per clone were lower in samples from IFN-c receptor a-deficient
mice than in wild-type mice [36]. In our study, we cannot exclude
the possibility that the observed difference in the accumulation of
vlsE variants in immunocompetent and SCID hosts is due in part
to alterations in IFN-c expression or other cytokine-mediated
pathways. Other infectious agents (including Escherichia coli,
Mycobacterium tuberculosis and Trypanosoma cruzi [37,38,39]) have
developed diverse ways to subvert the immune system through the
alteration of cytokine responses, so it is not outside the realm of
possibility that vlsE antigenic variation is influenced by host
cytokine production.
Full-length VlsE protein expression is not required for
sequence variation
The silent cassette vls11 sequence contains a stop codon within
invariable region 4 (IR4); recombination of this codon into vlsE
would result in translational termination and a truncated
polypeptide representing 63% of the full length VlsE [22,25]. In
the current study, 16 independent clones containing this stop
codon in the vlsE sequence were isolated in the population of 1,399
clones analyzed. To determine whether a clone containing this
stop codon in the vlsE sequence can colonize a mammalian host,
two clones, 1379A and D7M5H5, were inoculated into immuno-
competent C3H/HeN mice. The colonization of the mice was
successful, as demonstrated by the detection of organisms in the
skin at day 7 and in all tissues cultured at 28 days post infection
(data not shown). We cloned sequences from the vlsE expression
cassette to examine the ability of B. burgdorferi defective in full-
length VlsE expression to undergo vlsE recombination in mice.
Seven days after inoculation, bacteria recovered from back skin
biopsies from 5 mice were analyzed for vlsE recombination.
Interestingly, all 10 of the sequences analyzed still possessed the
stop codon, although 50% of the clones showed changes in other
parts of the vlsE sequence as compared to the sequence of the
parental clone 1379A (data not shown) . At day 28 post-infection,
vlsE sequences lacking the stop codon were recovered, indicating
that sequences derived from the vls11 silent cassette are capable of
undergoing recombination to generate full length VlsE. Taken
together, these results indicate that continuous expression of a full
length VlsE protein is not required for either the successful
colonization of mice or the occurrence of vlsE recombination. This
phenomenon could be considered a form of phase variation, as
occurs in the pilin expression system in Neisseria species [10]. These
data are also consistent with several previous studies indicating
that B. burgdorferi clones lacking either lp28-1 or the vls locus can
disseminate and survive for short periods (,18 days) in immuno-
competent mice, yet can apparently survive indefinitely in SCID
mice [23,24,33,40,41].
Predominance of short recombination events
To investigate the length of individual vlsE recombination
events, we performed a detailed examination of clones with only
one apparent event of recombination. These results comprised
126 independent clones recovered from all tested tissues from
both immunocompetent and SCID mice during the time course
of infection (Table 2). Variant sequences with a single event of
recombination encompassed a broad range of one (e.g.
D7M5J12) to 22 (e.g. D14M2B01) codon changes (Figure 4C).
The recombination observed in clone D7M5J12 represented
only a GGGRAAG conversion at codon 84 in the aligned
sequences, and could have arisen from any of the vls silent
cassettes containing the AAG codon at this position (vls3, vls8,
vls11, vls13, vls15 and vls16). In this case, the minimal
recombination event comprised only two nucleotides, whereas
possible maximal recombination events (the range in which the
variant sequence matches both the ‘recipient’ and ‘donor’
sequences on either side of the sequence change) ranged from
2 to 17 nt upstream and 21 to 37 nt downstream, depending on
the silent cassette involved. Overall, the recombination event in
this example involved a maximum of 25 to 48 nt of DNA,
indicating that vlsE recombination can take place in a very small
region. At the other end of the spectrum, the putative
recombination event with vls4 in clone D14M2B01 (Figure 4C)
encompassed a minimum of 349 nt and a maximum of 423 nt of
donor sequence, with 64 nt and 10 nt of sequence identity
flanking the region of sequence change on the upstream and
downstream ends, respectively. Thus the vlsE recombination
system appears to promote both minuscule and long recombi-
nation events within the cassette region.
A subset of 126 vlsE variants was identified that appeared to
represent ‘templated’ single recombination events (Table S2). All
of the sequence changes in this group had corresponding template
sequences in one or more silent cassettes, and most had regions of
homology with both the ‘donor’ and ‘recipient’ sequences both
upstream and downstream from the sequence change (e.g.
Figure 6. Median number of putative recombination events in
variant B. burgdorferi clones during the time course of infection.
Hatched and empty bars represent the populations of bacteria
recovered from C3H/HeN or SCID mice, respectively. ** indicates a
significant difference (P,0.01) between the results obtained for C3H/
HeN and SCID mice for that time point, as calculated by unpaired
Student’s t test.
doi:10.1371/journal.ppat.1000293.g006
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D7M5J12, Figure 4C). The majority of these clones (70 of 126, or
55%) exhibited a minimum region of recombination of 1 to 5
nucleotides (Figure 7A) Amazingly, 33 of 126 (26%) had only a
single nucleotide change (Figure 7A). These most likely represent
templated gene conversion events, because they occur at a much
higher frequency than that of template-independent single
Table 2. Number of vlsE sequences analyzed exhibiting a putative single recombination event.
Days post infection No. of sequences
C3H/HeN SCID
Bladder Heart Joint Ear Skin Bladder Heart Joint Ear Skin
4 days 1*
7 days 11 6 18 1 4
10 days 11 7 13 9 3 5 1 3
14 days 2 3 5 7 5 1 11*
28 days 1* 31* 51* 21* 31*
The description and key are the same as in Table 1.
doi:10.1371/journal.ppat.1000293.t002
Figure 7. Lengths of minimum and maximum predicted recombination events in 126 clones identified as having a single, well-
defined recombination event. Histograms of the deduced (A) minimum and (B) maximum lengths of recombination are depicted as bars; the
cumulative percentage of clones having predicted minimal or maximal recombination lengths#the length shown are represented as lines. Panel C
represents the putative silent cassette usage in clones with a single recombination event in which the silent cassette source could be determined
unambiguously.
doi:10.1371/journal.ppat.1000293.g007
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nucleotide sequence changes (76 of 1,073 sequences examined, or
7%) (Table S1).
An additional 28 clones (22%) exhibited minimal recombination
events of 6 to 14 nt, whereas only 28 clones (21%) had minimal
recombinations $15 nt. In contrast, the lengths of the predicted
maximum recombination events were more widely distributed
between 7 to 419 nucleotides (Figure 7B). (In this analysis, the
maximal recombination event was based on the longest region of
sequence identity if more than one silent cassette could have
served as the ‘donor’ for the recombination event.) These results
indicate that the length of DNA that is utilized during the
recombination process is highly variable, but tends to include a
short region of nonhomologous DNA. The observed median
minimal recombination (6S.E.) was 560.27 nt, whereas the
median maximal recombination (6S.E.) was 8960.37 nt. The
difference between minimal and maximal recombinations reflects
the high homology between the silent cassette sequences and the
vlsE cassette region. Thus, each round of vlsE gene conversion (i.e.
each vlsE recombination event) often introduces only one or two
amino acid changes in each variant protein sequence, although a
much larger region may be involved in each recombination event.
To examine this mechanism further, the base changes occurring in
33 well-defined ‘templated’ single nucleotide changes (proposed
gene conversion events) were compared with 76 ‘template-
independent’ changes (Table S3). While the proportion of
nucleotide conversions were similar overall, CRA transversions
were favored in the templated group, and CRG transversions
were predominant in the template-independent group; this result
implies that different mechanisms are operative in the two groups.
While we cannot determine conclusively whether single nucleotide
changes were introduced by genetic recombination or hypermuta-
tion as previously proposed by Sung et al. [35], our study indicates
that most sequence changes in vlsE result from gene conversion
events between the vls silent cassettes and the vlse1 expression
cassette.
Silent cassette usage as recombination template
The putative silent cassette usage was determined for the
sequence of clones showing a single, non-ambiguous recombina-
tion event (Figure 7C). We observed that some silent cassettes,
including vls6, vls7, vls9, appeared to be used more often than the
others. Although it had been proposed previously that the 17 bp
direct repeat sequences present at the 59 and 39 ends of each silent
cassette are involved in vlsE recombination [22], those silent
cassettes with poorly conserved direct repeats (e.g. cassettes 10 and
11) are used during vlsE variation (Figure 7C). In the population of
clones with a single recombination event, no clones were identified
in which silent cassettes vls2, vls14 and vls16 were used as template
for recombination. To extend this analysis, we also identified well-
separated, unambiguous recombination events in all 1,073 clones
with vlsE variations, including those with multiple recombination
events. In this extended group, examples where vls2, vls14 or vls16
were unambiguously used as template were observed (data not
shown). These results indicates that any region of any silent
cassette can be use as template, although the silent cassettes
present in the central part of the silent cassette locus tend to be
used more frequently.
Distribution of sequence variations within the vlsE
cassette region
In our study, we analyzed the location of sequence changes
within the vlsE cassette region during the time course of infection.
No evidence of a recombination ‘program’ in which recombina-
tions involved certain variable regions earlier than others was
observed (data not shown). We also checked each individual
variant amino acid sequence to determine if a specific VlsE protein
sequence can be linked with a specific tissue tropism. In the
relapsing fever organism Borrelia turicatae, the variable large
protein/variable small protein (Vlp/Vsp) antigenic variation
system influences tissue tropism as well as immune evasion
[42,43]. For example, B. turicatae expressing VspA are neurotropic
while those expressing VspB achieve higher concentrations in the
blood in a mouse model [42,43]. In our study, there were no
obvious differences in the amino acid sequence changes observed
in different tissues (Figure 8). These results suggest that the vlsE
gene conversion system is primarily involved in immune evasion
rather than tissue tropism. Interestingly, we were also able to
identify 5 pairs of clones presenting the exact same variant
sequence in different tissues of the same mouse (e.g. D28M2BX1
from bladder and D28M2HX6 from heart); an additional 33 pairs
of identical variants in different tissues were identified in other
mice. These findings verify the occurrence of dissemination of
variant clones in individual mice.
Conclusion
The vls antigenic variation system is an example of segmental
gene conversion, which is also found in the N. gonorrhoeae pilE
system [44], the A. marginale msp2 system [13], and the Babesia
bovis ves1a system [45]. In each of these systems, a set of silent
gene segments serves as the source of the ‘donor’ sequence, but
the donor site remains unaltered in progeny following the
recombination. Also, the recombination events occur at a high
rate within the target gene, indicating that special mechanisms
facilitate unidirectional genetic change in the target site (but not
the donor sites). Another unusual property shared by segmental
gene conversion mechanisms is that the recombination is
‘unanchored’ within the target gene, i.e. it does not start or
stop at a certain sequence. The relapsing fever antigenic
variation system is different in this aspect, in that most gene
conversion recombination events occur at specific upstream and
downstream homology sequences [16]. Our data also indicated
that very short recombinations occur in the vls system, and that
long flanking regions of sequence identity between the donor
and recipient sequences are not required. Indeed, in our analysis
of probable single recombination events, there were examples
where there was no sequence identity on one end or the other of
the recombination (e.g. clones D7M3B12, D10M9H6, and
D10M7J4). The day 7 joint isolate D7M2J05 (data not shown)
exemplified clones with short segments of sequence identity at
both ends of the recombination, with regions of identity of only
2 nt and 6 nt upstream and downstream of an 11 nt region of
sequence replacement (from cassette 10). These results indicate
that the vls recombination system requires very little sequence
identity to initiate the recombination event. In this regard, the
vls system appears to be similar to the N. gonorrhoeae pilE system,
in which sequence changes ranging in size from as short as 1 nt
to as long as 200 nt have been observed; in addition, over 50%
of the recombinations are 15 nt or less [44,46,47]. In no case,
however, has illegitimate recombination into nonhomologous
sites been observed in vlsE (or pilE), demonstrating that some
extent of sequence complementarity and alignment is needed to
‘nucleate’ the recombination event.
The mechanisms involved in segmental gene conversion
during antigenic variation are not well understood. pilE
sequence variation is RecA-dependent [48], and appears to
involve circular intermediates that are derived from pilS silent
cassette sequences [49]. We propose that a vls silent cassette
sequence (in the form of lp28-1, a separate episomal DNA copy,
vlsE Recombination in Mice
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or possibly even an RNA copy) undergoes strand invasion,
displacing the parental strain. This process requires very short
regions of sequence identity and could be facilitated by a DNA-
binding protein or endonuclease to nick the recipient and/or
donor DNA, although the lack of specificity in terms of the site
of sequence change suggests that these activities would not be
very site-specific. The strand invasion also appears to be
terminated in a non-specific manner, in that the lengths of
recombination were variable (although predominantly short).
Termination may not require a region of sequence identity, in
that there were examples where no region of sequence identity
was found at one end of the vlsE sequence change. We believe
that as yet unidentified mediators of vlsE recombination are
induced or activated during mammalian infection, as evidenced
by rapid occurrence of vlsE sequence changes during mamma-
lian infection and the lack of detectable sequence variation
during in vitro culture or tick infection. (Alternatively, an
inhibitor of vlsE recombination could be repressed or inactivat-
ed during mouse infection; however, this scenario seems unlikely
in that vlsE recombination has not been observed in E. coli
transformed with constructs containing vlsE and an adjacent
region of the silent cassettes [S. J. N. and J. K. Howell,
unpublished data].) Study of this phenomenon and its cis- and
trans-acting mediators would be aided greatly by the identifica-
tion of conditions that activate vlsE recombination in vitro, or vls
shuttle constructs that undergo recombination in B. burgdorferi
and can be genetically manipulated to permit the identification
of cis-acting elements.
Antigenic variation and phase variation in bacterial surface
proteins are common and have been shown to contribute to
avoidance of adaptive immune responses, to tissue tropism, or to
the pathogenesis process (e.g. altered adherence properties). Our
studies provide direct in vivo evidence of the function of gene
conversion of the Borrelial VlsE lipoprotein. In wild-type mice
(in comparison with SCID mice), clones having the parental vlsE
sequence persist for a shorter period; in addition, vlsE codon
changes and recombination events accumulate more rapidly.
These data indicate that variants are selected in immunocom-
petent mice, most likely due to antibodies specific for the variable
regions of VlsE [32]. Similar results have been observed in the
Vlp/Vsp antigenic variation system of relapsing fever Borrelia
[50] and the Vsa phase variation system in Mycoplasma pulmonis
[12]. The adaptive immune system thus acts as a selective force,
killing clones with less variation but not eliminating clones with
more extensive variation (and hence antigenic differences). In
this study and as previously observed by Zhang and Norris [25],
the presence or absence of the adaptive immune system is not
required to induce the vlsE gene conversion mechanism.
However, we cannot rule out the possibility that the adaptive
immune system can directly affect the kinetics of the ongoing
process of vlsE recombination, i.e. that the bacteria exhibit
increased recombination under the influence of immune pressure
(e.g. production of specific antibody or cytokines) [36]. Indeed,
vlsE expression is increased under the influence of the immune
pressure, specifically when functional B cells are present [51]. An
interesting experiment would be to follow the rate of vlsE variant
accumulation during the time course of infection of immuno-
competent or SCID mice previously immunized with recombi-
nant VlsE protein. An additional finding was that the production
of a stable VlsE protein is not required for the vlsE gene
conversion process to occur. Any silent cassette (and any region
thereof) can be involved in a recombination event, and a variety
of apparent template-independent genetic changes contributed
to sequence variation. The recombination events are evenly
distributed throughout the vlsE cassette region and exhibit no
apparent bias for particular regions. Furthermore, no VlsE motif
was associated with infection of a specific tissue site. The degree
of variation observed indicates that the vlsE recombination
system is one of the most robust antigenic variation systems
found in pathogens.
Figure 8. The locations and amino acid utilization of deduced VlsE amino acid changes paralleled the changes predicted by the
sequence differences between vlsE1 and the silent cassettes. The distribution of amino acid changes found in the variant sequences from
different infected tissues were depicted as sequence logo patterns using the program WebLogo [54]. The height of the letter is proportional to the
frequency of changes. The letter ‘‘x’’ indicates a 3-nt indel, and the asterisk a stop codon. The panels for bladder, heart, joint, ear, and skin represent
the observed changes in the variant sequences recovered from the respective tissue at all time points during B. burgdorferi infection of C3H/HeN or
SCID mice. The silent cassette panel represents the relative probability of a given amino acid change at each position of vlsE1, based on the amino
acids encoded by the silent cassette sequences at each position in the vlsE1/silent cassette alignment.
doi:10.1371/journal.ppat.1000293.g008
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Materials and Methods
Bacterial strains and cultures
The high-infectivity B. burgdorferi B31 clones 5A3 (B31-5A3,
lacking plasmids lp28-2 and lp56) and 5A4 (B31-5A4, containing
all plasmids) were isolated previously from low-passage strain B31
[27]. Small quantities were removed from the surface of frozen
stocks by scraping with sterile 1 ml pipet tips and were inoculated
into 6 ml of BSKII medium [52]. Cultures used in this study had
undergone no more than two passages since clone isolation, thus
minimizing the likelihood of plasmid loss.
Animal studies
All research involving animals was approved by the Animal
Welfare Committee of the University of Texas Health Science
Center at Houston. Eight-week-old, female C3H/HeN mice
(Harlan, Indianapolis, IN), C3H/HeN severe combined immuno-
deficiency (SCID) mice (Harlan) and CB-17 SCID mice (Charles
River Laboratories, Wilmington, MA) were housed in micro-
isolator cages and provided with antibiotic-free food and water.
For mouse inoculation, frozen stocks of low passage B. burgdorferi
strains were cultured in BSK II medium [52] at 37uC in 3% CO2
until the mid-log phase of growth. The cultures were diluted in
BSK II medium to a concentration of 106 bacteria/ml as
determined by dark-field microscopy, and 0.1 ml (105 organisms)
was injected subcutaneously at the base of the tail. Groups of 4 to 6
mice were sacrificed on 4, 7, 10, 14 and 28 days post infection,
and samples from tissue sites (bladder, heart, joint, ear and skin)
were acquired under aseptic conditions and cultured in 6 ml of
BSK II broth with an antibiotic mixture to reduce the occurrence
of microbial contamination (Sigma Aldrich; 50 mg/ml rifampin,
20 mg/ml phosphomicin and 2.5 mg/ml amphotericin B). After
7 days, the cultures were checked for growth, diluted, and
subsurface plated in BSKII-agarose medium to obtain individual
clones as described previously [53].
Amplification and sequencing of vlsE cassette region
Well-isolated colonies from BSKII-agarose plates were inocu-
lated in BSK II medium with antibiotics and cultured for 4 days
prior to use as PCR templates (<104 cells per reaction).
Alternatively, agarose plugs containing individual colonies were
added directly to the PCR reaction. The vlsE cassette region of
each clone was amplified by PCR using the Phusion High-Fidelity
DNA Polymerase (New England BioLabs, Ipswich, MA) and vlsE
primers 4066 and 4120 as described previously [25]. The PCR
products were purified and sequenced on both strands at the High-
Throughput Genomics Unit (Department of Genome Sciences,
University of Washington , Seattle), utilizing the same primers
used for the amplification. The PCR products were sequenced
directly (without cloning the products) to minimize the effects of
sequence errors due to PCR infidelity. The chromatographs
corresponding to each DNA sequence were examined individually
to verify the quality of the sequence data, and each sequence
difference (in comparison to the parental vlsE1 sequence) was
checked for sequence accuracy. Variant clones that originated
from the same tissue specimen and had identical sequences were
considered siblings but were treated separately in this analysis.
vlsE variant sequence analysis
The B31 parental vlsE (allele vlsE1), vls silent cassettes, and all of
the vlsE variants sequences presented in this study are contained in
GenBank entries U76406, U76405, EU484573–EU485396,
EU485400–EU485403, EU485405–EU485714, EU485716–
EU485724, EU485726–EU48748, and EU485750–EU485984; a
list of the clone numbers and the corresponding GenBank
accession numbers is at http://www.uth.tmc.edu/pathology/
borrelia/. Most clone numbers are in the following format:
S = SCID mouse infection; D4= 4 days post infection;
M3=mouse 3; B, E, H, J, S = bladder, ear, heart, tibiotarsal
joint, and skin, respectively; number and/or letter designation-
s = individual clone from that animal and tissue. An ‘X’ indicates
that a colony PCR product was sequenced, and no B. burgdorferi
culture was retained. Infecting clone refers to either B31 5A3
(lacking plasmids lp28-2 and lp56) or B31 5A4 (containing all
plasmids).
The DNA sequences of the parental vlsE cassette region (vls1)
and the silent cassettes (vls2 to vls16) were aligned manually to
match the arrangement in Figure 3 of Zhang et al. [22], and their
sequences were formatted into codons (corresponding to vlsE
codons). Indels were recorded using the letters ‘‘OOO’’ as a place
marker. The aligned sequences were inserted into a MicrosoftH
Excel spreadsheet (one codon per cell), creating the template used
to analyze vlsE variant sequences. Each vlsE variant sequence was
codon-formatted, trimmed, and optimally aligned with vls1 (using
the ClustalW multiple alignment algorithm embedded in the
Bioedit software [http://www.mbio.ncsu.edu/BioEdit/BioEdit.
html] (followed by manual adjustments) prior to analysis. The
sequences were then compared to the parental vls1 sequence and
the silent cassette sequences using a set of macros written using
MicrosoftH Visual Basic for Applications. The Excel template and
macros may be obtained by contacting the authors.
The nucleotide and deduced amino acid sequences of each
variant were compared computationally to both vls1 and the silent
cassette nucleotide and predicted amino acid sequences. We first
analyzed the overall number of codon differences between vls1 and
the variant sequence. The codon sequence for each individual
observed difference was compared to the sequences present among
the silent cassettes at the same position, thus determining the
putative silent cassette source(s) of any non-parental codon found
in a given variant sequence. By combining the location and the
possible silent cassette sources for each change in a variant
sequence, we were able to identify regions of sequence variation
and to propose putative events of recombination as well as the
silent cassettes potentially used as templates. For each region of
sequence variation, the minimal deduced regions of recombination
were defined as groups of contiguous codons differing from the
parental sequence and matching a silent cassette sequence,
whereas the maximal deduced regions of recombination included
all contiguous codons in either direction in which the variant
sequence matched both the parental and silent cassette sequences.
The possible recombination events were thus determined
computationally and portrayed graphically by the ExcelTM
spreadsheet, as exemplified in Figure 4. In cases where more
than one silent cassette could serve as the template for a
recombination event, the silent cassette showing the longest
maximal recombination pattern was selected as the possible
template.
Positional changes in vlsE variants with time
By comparing the silent cassette sequences and the vls1
sequence, we determined the probability of change at each codon
in vls1. Each vlsE variant sequence was then compared to vls1 to
determine the number and position of codon and amino acid
differences in that variant. The results obtained for variant
sequences at a given time post infection were analyzed together,
and the total number of differences at each position was
calculated, normalized for the number of variants, and compared
with the probability of change at each position in vls1. The
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deduced amino acid changes occurring at each position were also
compared to probability data obtained from vlsE1/silent cassette
comparisons and displayed using the program WebLogo [54].
Statistical analyses
Statistics were performed in MicrosoftH Excel using the
unpaired Student’s t test.
Supporting Information
Table S1 B. burgdorferi vlsE variant clones with template-
independent sequence changes.
Found at: doi:10.1371/journal.ppat.1000293.s001 (0.12 MB PDF)
Table S2 B. burgdorferi vlsE variant clones with sequences
consistent with a single recombination event.
Found at: doi:10.1371/journal.ppat.1000293.s002 (0.11 MB PDF)
Table S3 Comparison of the base changes occurring in
‘templated’ vs. ‘template-independent’ single nucleotide changes
in vlsE variants.
Found at: doi:10.1371/journal.ppat.1000293.s003 (0.08 MB PDF)
Figure S1 D28M1HX5 as an example of a vlsE variant with
templated and template-independent sequence modifications.
Possible involvement of silent cassette sequences vls2–vls16 in vlsE
gene conversion events are shown by the colored bars, as described
in the legend for Fig. 4. Variant D28M1HX5 contains an
template-independent variations at codons 147 and 165. This
mismatch to any vls silent cassette is indicated by a 0 in the vlsE
match row as well as by the lack of color fill in the graphic column
of those codons. Variant D28M1HX5 has apparently undergone
multiple templated recombination events, with the most likely
‘donor’ sequences being vls6 (minimal recombination event = co-
dons 37–64), either vls3 or vls4 (98–127), vls7 or vls10 (141–144),
vls8 (156–162), and vls3 (169–201).
Found at: doi:10.1371/journal.ppat.1000293.s004 (0.09 MB XLS)
Figure S2 Locations of template-independent sequence varia-
tion. The X axis numbers represent the codon number of each
amino acid in vlsE as presented in Figure 3 of [22]. The dark blue
bars represent the number of variants recovered at each codon.
The black line represents a 3 point moving average. In the
diagram below the graph, the light areas indicate the locations of
the invariable regions of vlsE while the dark areas indicate the
positions of the variable regions of vlsE.
Found at: doi:10.1371/journal.ppat.1000293.s005 (0.07 MB PDF)
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